Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Compliance with SSRI medication during 6 months of treatment for major depression: an evaluation by determination of repeated serum drug concentrations.

Reis M, Aberg-Wistedt A, Agren H, Akerblad AC, Bengtsson F.

J Affect Disord. 2004 Nov 1;82(3):443-6.

PMID:
15555696
2.
3.

Therapeutic drug monitoring of sertraline: variability factors as displayed in a clinical setting.

Lundmark J, Reis M, Bengtsson F.

Ther Drug Monit. 2000 Aug;22(4):446-54.

PMID:
10942186
4.

Partial compliance as determined from plasma levels of sertraline and its metabolite in depressed patients in primary care.

Reis M, Akerblad AC, Ekselius L, von Knorring L.

J Clin Psychopharmacol. 2010 Dec;30(6):746-8. doi: 10.1097/JCP.0b013e3181fc2cf1. No abstract available.

PMID:
21057244
6.

The pharmacokinetics of sertraline excretion into human breast milk: determinants of infant serum concentrations.

Stowe ZN, Hostetter AL, Owens MJ, Ritchie JC, Sternberg K, Cohen LS, Nemeroff CB.

J Clin Psychiatry. 2003 Jan;64(1):73-80.

PMID:
12590627
7.

[Comparison of two assessment tools of antidepressant side-effects: UKU scale versus spontaneous notification].

Gruwez B, Gury C, Poirier MF, Bouvet O, Gérard A, Bourdel MC, Baylé FJ, Olié JP.

Encephale. 2004 Sep-Oct;30(5):425-32. French.

PMID:
15627047
8.

Long-term efficacy and therapeutic drug monitoring of sertraline in major depression.

Mauri MC, Fiorentini A, Cerveri G, Volonteri LS, Regispani F, Malvini L, Boscati L, Baido RL, Invernizzi G.

Hum Psychopharmacol. 2003 Jul;18(5):385-8.

PMID:
12858326
9.

[Use of antidepressant drugs in schizophrenic patients with depression].

Micallef J, Fakra E, Blin O.

Encephale. 2006 Mar-Apr;32(2 Pt 1):263-9. Review. French.

PMID:
16910628
10.

Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial.

Lustman PJ, Clouse RE, Nix BD, Freedland KE, Rubin EH, McGill JB, Williams MM, Gelenberg AJ, Ciechanowski PS, Hirsch IB.

Arch Gen Psychiatry. 2006 May;63(5):521-9.

PMID:
16651509
11.

Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trial.

Cooper-Kazaz R, Apter JT, Cohen R, Karagichev L, Muhammed-Moussa S, Grupper D, Drori T, Newman ME, Sackeim HA, Glaser B, Lerer B.

Arch Gen Psychiatry. 2007 Jun;64(6):679-88.

PMID:
17548749
12.
13.
14.

Escitalopram in major depressive disorder: a multicenter, randomized, double-blind, fixed-dose, parallel trial in a Chinese population.

Mao PX, Tang YL, Jiang F, Shu L, Gu X, Li M, Qian M, Ma C, Mitchell PB, Cai ZJ.

Depress Anxiety. 2008;25(1):46-54.

PMID:
17149753
15.

[Management strategies for major depressive episodes as a function of initial response to an SSRI or SNRI antidepressant: results of the ORACLE survey].

Spadone C, Sylvestre M, Chiarelli P, Richard-Berthe C.

Encephale. 2005 Nov-Dec;31(6 Pt 1):698-704. French.

PMID:
16462689
16.

HPLC analysis of the second-generation antidepressant sertraline and its main metabolite N-desmethylsertraline in human plasma.

Mandrioli R, Saracino MA, Ferrari S, Berardi D, Kenndler E, Raggi MA.

J Chromatogr B Analyt Technol Biomed Life Sci. 2006 May 19;836(1-2):116-9. Epub 2006 Apr 11.

PMID:
16581317
17.

T3 augmentation of SSRI resistant depression.

Abraham G, Milev R, Stuart Lawson J.

J Affect Disord. 2006 Apr;91(2-3):211-5. Epub 2006 Feb 17.

PMID:
16483669
18.

Efficacy and tolerability of adjunctive ziprasidone in treatment-resistant depression: a randomized, open-label, pilot study.

Dunner DL, Amsterdam JD, Shelton RC, Loebel A, Romano SJ.

J Clin Psychiatry. 2007 Jul;68(7):1071-7.

PMID:
17685744
19.

Serum concentrations of antidepressant drugs in a naturalistic setting: compilation based on a large therapeutic drug monitoring database.

Reis M, Aamo T, Spigset O, Ahlner J.

Ther Drug Monit. 2009 Feb;31(1):42-56. doi: 10.1097/FTD.0b013e31819114ea.

PMID:
19077925
20.

Randomized trial of sertraline versus venlafaxine XR in major depression: efficacy and discontinuation symptoms.

Sir A, D'Souza RF, Uguz S, George T, Vahip S, Hopwood M, Martin AJ, Lam W, Burt T.

J Clin Psychiatry. 2005 Oct;66(10):1312-20.

PMID:
16259546

Supplemental Content

Support Center